跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Seretide - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Seretide
Approved
STANDARD
Seretide
Glaxo Wellcome S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b38248e85af61f4c
Company
Glaxo Wellcome S.A.
Type
Standard
Approval Details
Approval Id
b38248e85af61f4c
Drug Approval Philippines Name
Seretide
Product Name
Seretide
Registration Number
DRP-5118
Brand Name
Seretide
Generic Name
Salmeterol (As Xinafoate) + Fluticasone Propionate
Dosage Form
Metered Dose Inhaler (Suspension)
Dosage Strength
25 mcg/250 mcg
Manufacturer
Glaxo Wellcome S.A.
Importer
GlaxoSmithKline Philippines, Inc.
Issuance Date
25 July 2022
Expiry Date
25 July 2027
Pharmacologic Category
Beta-2-Adrenoceptor Agonist/ Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b38248e85af61f4c
Type
Standard
Back to Philippines FDA Approvals